Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC

Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

(2020) Ning Tang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

(2020) Xiaobo Yang et al.   Lancet Respiratory Medicine

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

(2020) Dominic Wichmann et al.   ANNALS OF INTERNAL MEDICINE

Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): A case series

(2020) Janice Wang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19

(2020) Claire S Whyte et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Early Outcomes with Utilization of Tissue Plasminogen Activator in COVID-19 Associated Respiratory Distress

(2020) D. Benjamin Christie et al.   Journal of Trauma and Acute Care Surgery

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

Plasminogen improves lung lesions and hypoxemia in patients with COVID-19

(2020) Yuanyuan Wu et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis

(2020) Rashikh Choudhury et al.   World Journal of Emergency Surgery

The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

(2020) Dennis McGonagle et al.   AUTOIMMUNITY REVIEWS

Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis

(2020) Christophe Nougier et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Tissue‐type plasminogen activator neutralizes LPS but not protease‐activated receptor‐mediated inflammatory responses to plasmin

(2019) Cristina Zalfa et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Streptokinase versus Unfractionated Heparin Nebulization in Patients with Severe Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial with Observational Controls

(2019) Ahmed Abdelaal Ahmed Mahmoud et al.   JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA